Resverlogix (TSX:RVX) Cyclically Adjusted PB Ratio: (As of Aug. 05, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSX:RVX Resverlogix Corp TSX:RVX
17 GF Score
Price C$0.10
! 5 Warning Signs
View Full Analysis

What is Resverlogix Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Resverlogix  (TSX:RVX) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Resverlogix Cyclically Adjusted PB Ratio Related Terms


Resverlogix Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Resverlogix's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Resverlogix Cyclically Adjusted PB Ratio Chart

Resverlogix Annual Data
Trend Apr16 Apr17 Apr18 Apr19 Apr20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Resverlogix Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

TSX:RVX vs VRTX, REGN, RVMD: Cyclically Adjusted PB Ratio Comparison

For the Biotechnology subindustry, Resverlogix's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Resverlogix Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Resverlogix's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Resverlogix's Cyclically Adjusted PB Ratio falls into.


TSX:RVX
17GF Score
Resverlogix Corp TSX:RVX
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Resverlogix Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Resverlogix's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 is calculated as:

For example, Resverlogix's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book=Book Value per Share/CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.392/132.2623*132.2623
=-0.392

Current CPI (Mar. 2026) = 132.2623.

Resverlogix Quarterly Data

Book Value per Share CPI Adj_Book
201604 -0.688 101.370 -0.898
201607 -0.777 101.844 -1.009
201610 -0.977 102.002 -1.267
201701 -1.131 102.318 -1.462
201704 -1.292 103.029 -1.659
201707 -1.269 103.029 -1.629
201710 -1.307 103.424 -1.671
201801 -0.557 104.056 -0.708
201804 -0.601 105.320 -0.755
201807 -0.984 106.110 -1.227
201810 -1.075 105.952 -1.342
201901 -1.066 105.557 -1.336
201904 -1.387 107.453 -1.707
201907 -1.246 108.243 -1.522
201910 -0.517 107.927 -0.634
202001 -0.465 108.085 -0.569
202004 -0.425 107.216 -0.524
202007 -0.418 108.401 -0.510
202010 -0.298 108.638 -0.363
202103 -0.209 110.298 -0.251
202106 -0.195 111.720 -0.231
202109 -0.227 112.905 -0.266
202112 -0.315 113.774 -0.366
202203 -0.309 117.646 -0.347
202206 -0.306 120.806 -0.335
202209 -0.304 120.648 -0.333
202212 -0.303 120.964 -0.331
202303 -0.327 122.702 -0.352
202306 -0.330 124.203 -0.351
202309 -0.356 125.230 -0.376
202312 -0.367 125.072 -0.388
202403 -0.360 126.258 -0.377
202406 -0.384 127.522 -0.398
202409 -0.402 127.285 -0.418
202412 -0.414 127.364 -0.430
202503 -0.439 129.181 -0.449
202506 -0.423 129.892 -0.431
202509 -0.429 130.287 -0.436
202512 -0.427 130.366 -0.433
202603 -0.392 132.262 -0.392

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Resverlogix Business Description

Other Exchanges RVXCF:USA
Address 4820 Richard Road SW, Suite 300, Calgary, AB, CAN, T3E 6L1
Resverlogix Corp clinical-stage biotechnology company. The company is developing apabetalone (RVX-208), a first-in-class, small molecule that is a selective BET (bromodomain and extra-terminal) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. Apabetalone is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. This selective inhibition of apabetalone on BD2 produces a specific set of biological effects with potentially important benefits for patients with chronic disease, including cardiovascular disease (CVD) and associated comorbidities, and COVID-19.
17GF Score

Get the complete analysis for TSX:RVX

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$0.10
Price